Adaptimmune Therapeutics Plc ADR (ADAPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,139 | 143,991 | 108,033 | 149,948 | 56,882 |
| Marketable Securities | 60,466 | 2,947 | 96,572 | 219,632 | 311,335 |
| Receivables | 1,454 | 821 | 7,435 | 752 | 139 |
| Inventories | 7,320 | N/A | N/A | N/A | N/A |
| Other current assets | 27,790 | 59,793 | 43,330 | 45,126 | 29,796 |
| TOTAL | $188,169 | $207,552 | $255,370 | $415,458 | $398,152 |
| Non-Current Assets | |||||
| PPE Net | 31,309 | 50,946 | 53,516 | 30,494 | 27,778 |
| Intangibles | 3,880 | 330 | 442 | 1,000 | 1,730 |
| Other Non-Current Assets | 22,605 | 23,788 | 19,588 | 22,593 | 23,482 |
| TOTAL | $57,794 | $75,064 | $73,546 | $54,087 | $52,990 |
| Total Assets | $245,963 | $282,616 | $328,916 | $469,545 | $451,142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,692 | 8,128 | 4,753 | 8,113 | 6,389 |
| Accrued Expenses | 32,919 | 30,303 | 31,215 | 29,909 | 27,079 |
| Other current liabilities | 5,911 | N/A | 2,285 | N/A | N/A |
| TOTAL | $64,527 | $72,788 | $64,501 | $62,541 | $39,073 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50,237 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 12,296 | 28,973 | 23,520 | 22,199 | 2,832 |
| Other Non-Current Liabilities | 23,535 | 21,255 | 21,645 | 23,821 | 21,582 |
| TOTAL | $169,587 | $170,315 | $182,537 | $201,044 | $70,842 |
| Total Liabilities | $234,114 | $243,103 | $247,038 | $263,585 | $109,915 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 257,232 | 246,825 | 165,305 | 156,732 | 155,138 |
| Common Shares | 2,085 | 1,865 | 1,399 | 1,337 | 1,325 |
| Retained earnings | -1,093,987 | -1,023,173 | -909,302 | -743,846 | -585,756 |
| Other shareholders' equity | -1,902 | -3,748 | -875 | -11,142 | -10,048 |
| TOTAL | $11,849 | $39,513 | $81,878 | $205,960 | $341,227 |
| Total Liabilities And Equity | $245,963 | $282,616 | $328,916 | $469,545 | $451,142 |